Appin, C. L., & Brat, D. J. (2015). Molecular pathways in gliomagenesis and their relevance to neuropathologic diagnosis. Advances in Anatomic Pathology, 22(1), 50–58. https://doi.org/10.1097/pap.0000000000000048FromNLM
Article CAS PubMed Google Scholar
Aushev, V. N., Gopalakrishnan, K., Teitelbaum, S. L., ParadaJr, H., Santella, R. M., Gammon, M. D., & Chen, J. (2019). Tumor expression of environmental chemical-responsive genes and breast cancer mortality. Endocrine Related Cancer, 26(12), 843–851. https://doi.org/10.1530/erc-19-0357FromNLM
Article CAS PubMed Google Scholar
Bauché, D., Joyce-Shaikh, B., Jain, R., Grein, J., Ku, K. S., Blumenschein, W. M., Ganal-Vonarburg, S. C., Wilson, D. C., McClanahan, T. K., Malefyt, R. W., Macpherson, A. J., Annamalai, L., Yearley, J. H., Cua, D. (2018). LAG3+ regulatory T Cells restrain interleukin-23-producing CX3CR1+ gut-resident macrophages during group 3 innate lymphoid cell-driven colitis. Immunity, 49(2), 342–352. https://doi.org/10.1016/j.immuni.2018.07.007
Benyamin, B., Esko, T., Ried, J. S., Radhakrishnan, A., Vermeulen, S. H., Gögele, T., Anderson, D., Broer, L., Podmore, C., Luan, J., Kutalik, Z., Sanna, S., van der Meer, P., Tanaka, T., Wang, F., Westra, H-J., Franke, L., Mihailov, E., Milani, L., Hälldin, J., Winkelmann, J., Meitinger, T., Thiery, J., Peters, A., Waldenberger, M., Rendon, A., Jolley, J., Sambrook, J., Kiemeney, L., Sweep, F. C., Sala, C. F., Schwienbacher, C., Irene Pichler, I., Jennie Hui, J., Demirkan, A., Isaacs, A., Amin, N., Maristella Steri, M., Gérard Waeber, G., Verweij, N., Powell, J. E., Nyholt, D. R., Heath, A. C., Madden, P. A. F., Visscher, P. M., Wright, M. J., Montgomery, G. W., Martin, N. G., Hernandez, D., Bandinelli, S., van der Harst, P., Uda, M., Vollenweider, P., Scott, R. A., Langenberg, C., Wareham, N. J., Consortium, I., van Duijn, C., Beilby, J., Pramstaller, P. P., Hicks, A. A., Ouwehand, W. H., Oexle, K., Gieger, C., Metspalu, A., Camaschella, C., Toniolo, D., Swinkels, D. W., & Whitfield J. B. (2014). Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. Nature Communications, 5, 4926. https://doi.org/10.1038/ncomms5926FromNLM
Beroukhim, R., Getz, G., Nghiemphu, L., Barretina, J., Hsueh, T., Linhart, D., Vivanco, I., Lee, J. C., Huang, J. H., Alexander, S., Du, J., Kau, T., Thomas, R. K., Shah, K., Soto, H., Perner, S., Prensner, J., Debiasi, R. M., Demichelis, F., Hatton, C., Rubin, M. A., Garraway, L. A., Nelson, S. F., Liau, L., Mischel, P. S., Cloughesy, T. F., Meyerson, M., Golub, T. A., Lander, E. S., Mellinghoff, I. K., Sellers, W. R. (2007). Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proceedings of the National Academy of Sciences, 104(50), 20007–20012. https://doi.org/10.1073/pnas.0710052104FromNLM
Blain, K. Y., Kwiatkowski, W., Zhao, Q., La Fleur, D., Naik, C., Chun, T. W., Tsareva, T., Kanakaraj, P., Laird, M. W., Shah, R., George, L., Sanyal, I., Moore, P. A., Demeler, B., and Choe, C. (2007). Structural and functional characterization of CC chemokine CCL14. Biochemistry, 46(35), 10008–10015. https://doi.org/10.1021/bi700936wFromNLM
Bredel, M., Bredel, C., Juric, D., Harsh, G. R., Vogel, H., Recht, L. D., & Sikic, B. I. (2005). Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Research, 65(19), 8679–8689. https://doi.org/10.1158/0008-5472.Can-05-1204FromNLM
Article CAS PubMed Google Scholar
Brissot, P., Pietrangelo, A., Adams, P. C., de Graaff, B., McLaren, C. E., & Loréal, O. (2018). Haemochromatosis. Nature Reviews Disease Primers, 4, 18016. https://doi.org/10.1038/nrdp.2018.16FromNLM
Article PubMed PubMed Central Google Scholar
Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021). Broadening horizons: The role of ferroptosis in cancer. Nature Reviews Clinical Oncology, 18(5), 280–296. https://doi.org/10.1038/s41571-020-00462-0FromNLM
Article CAS PubMed Google Scholar
Chong, W. P., Mattapallil, M. J., Raychaudhuri, K., Bing, S. J., Wu, S., Zhong, Y., Wang, W., Chen, Z., Silver, P. B., Jittayasothorn, Y., Chan C. C., Chen, J., Horai, R., Caspi, R. R. (2020). The cytokine IL-17A limits Th17 pathogenicity via a negative feedback loop driven by autocrine induction of IL-24. Immunity, 53(2), 384-397. https://doi.org/10.1016/j.immuni.2020.06.022
Article CAS PubMed PubMed Central Google Scholar
Daubon, T., Hemadou, A., Romero Garmendia, I., & Saleh, M. (2020). Glioblastoma immune landscape and the potential of new immunotherapies. Frontiers in Immunology, 11, 585616. https://doi.org/10.3389/fimmu.2020.585616FromNLM
Article CAS PubMed PubMed Central Google Scholar
Deng, S., Zheng, Y., Mo, Y., Xu, X., Li, Y., Zhang, Y., Liu, J., Chen, J., Tian, Y., & Ke, Y. (2021). Ferroptosis suppressive genes correlate with immunosuppression in glioblastoma. World Neurosurg, 152, e436–e448. https://doi.org/10.1016/j.wneu.2021.05.098FromNLM
Donovan, A., Lima, C. A., Pinkus, J. L., Pinkus, G. S., Zon, L. I., Robine, S., & Andrews, N. C. (2005). The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metabolism, 1(3), 191–200. https://doi.org/10.1016/j.cmet.2005.01.003FromNLM
Article CAS PubMed Google Scholar
Drakesmith, H., Nemeth, E., & Ganz, T. (2015). Ironing out ferroportin. Cell Metabolism, 22(5), 777–787. https://doi.org/10.1016/j.cmet.2015.09.006FromNLM
Article CAS PubMed PubMed Central Google Scholar
Fang, X., Huang, Z., Zhai, K., Huang, Q., Tao, W., Kim, L., Wu, Q., Almasan, A., Yu, J. S., Li, X., Strak, G. R., Rich, J. N., Bao, S. (2021). Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.abc7275
Funakoshi, N., Chaze, I., Alary, A. S., Tachon, G., Cunat, S., Giansily-Blaizot, M., Bismuth, M., Larrey, D., Pageaux, G. P., Schved, J. F., Donnadieu-Rigole, H., Blanc, P., Aguilar-Martinez, P. (2016). The role of genetic factors in patients with hepatocellular carcinoma and iron overload—a prospective series of 234 patients. Liver International, 36(5), 746–754. https://doi.org/10.1111/liv.12984FromNLM
Herrmann, A., Lahtz, C., Nagao, T., Song, J. Y., Chan, W. C., Lee, H., Yue, C., Look, T., Mülfarth, R., Li, W., Jenkins, K., Williams, J., Budde, L. E., Forman, S., Kwak, L., Blankenstein, T., Yu, H. (2017). CTLA4 Promotes Tyk2-STAT3–Dependent B-cell Oncogenicity. Abstract Cancer Research, 77(18), 5118–5128. https://doi.org/10.1158/0008-5472.CAN-16-0342
Huang, Y. H., Zhu, C., Kondo, Y., Anderson, A. C., Gandhi, A., Russell, A., Dougan, S. K., Petersen, B. S., Melum, E., Pertel, T., Clayton, K. L., Raab, M., Chen, Q., Beauchemin, N., Yazaki, P. J., Pyzik, M., Ostrowski, M. A., Glickman, J. N., Rudd, C. E., Ploegh, H. L., Franke, A., Petsko, G. A., Kuchroo, V. K., Blumberg, R. S. (2015) CEACAM1 regulates TIM-3-mediated tolerance and exhaustion. Nature, 517(7534), 386–390. https://doi.org/10.1038/nature13848
Jagot, F., Gaston-Breton, R., Choi, A. J., Pascal, M., Bourhy, L., Dorado-Doncel, R., Conzelmann, K. K., Lledo, P. M., Lepousez, G., Eberl, G. (2023). The parabrachial nucleus elicits a vigorous corticosterone feedback response to the pro-inflammatory cytokine IL-1β. Neuron, 111(15), 2367–2382. https://doi.org/10.1016/j.neuron.2023.05.009
Article CAS PubMed Google Scholar
Kahn, J., Hayman, T. J., Jamal, M., Rath, B. H., Kramp, T., Camphausen, K., & Tofilon, P. J. (2014). The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells. Neuro-Oncology, 16(1), 29–37. https://doi.org/10.1093/neuonc/not139FromNLM
Article CAS PubMed Google Scholar
Khasraw, M., & Lassman, A. B. (2010). Advances in the treatment of malignant gliomas. Current Oncology Reports, 12(1), 26–33. https://doi.org/10.1007/s11912-009-0077-4FromNLM
Article CAS PubMed Google Scholar
Komohara, Y., Ohnishi, K., Kuratsu, J., & Takeya, M. (2008). Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. The Journal of Pathology, 216(1), 15–24. https://doi.org/10.1002/path.2370FromNLM
Article CAS PubMed Google Scholar
Korur, S., Huber, R. M., Sivasankaran, B., Petrich, M., Morin, P., Jr., Hemmings, B. A., Merlo, A., & Lino, M. M. (2009). GSK3beta regulates differentiation and growth arrest in glioblastoma. PLoS ONE, 4(10), e7443. https://doi.org/10.1371/journal.pone.0007443FromNLM
Article PubMed PubMed Central Google Scholar
Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., Park, J. K., Fine, H. A. (2006). Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell, 9(5), 391–403. https://doi.org/10.1016/j.ccr.2006.03.030FromNLM
Liang, B., Zhou, C., Cui, S., Lu, H., Xu, R., Xue, D., Zou, S., & He, X. (2021). Upregulation of miR-18a-5p promotes the proliferation of prostate cancer via inhibiting the expression of SLC40A1. Pathology, Research and Practice, 224, 153448. https://doi.org/10.1016/j.prp.2021.153448FromNLM
Article CAS PubMed Google Scholar
Liang, Y., Diehn, M., Watson, N., Bollen, A. W., Aldape, K. D., Nicholas, M. K., Lamborn, K. R., Berger, M. S., Botstein, D., Brown, P. O., Israel, M. A. (2005). Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proceedings of the National Academy of Sciences, 102(16), 5814–5819. https://doi.org/10.1073/pnas.0402870102FromNLM
Mattiola, I., Tomay, F., De Pizzol, M., Silva-Gomes, R., Savino, B., Gulic, T., Doni, A., Lonardi, S., Astrid Boutet, M., Nerviani, A.., Carriero, R., Molgora, M., Stravalaci,M., Morone, D., Shalova, I. N., Lee, Y., Biswas, S. K., Mantovani, G., Sironi, M., Pitzalis, C., Vermi, W., Bottazzi, B., Mantovani, A., & Locati, M. (2019). The macrophage tetraspan MS4A4A enhances dectin-1-dependent NK cell-mediated resistance to metastasis. Nature Immunology, 20(8), 1012–1022. https://doi.org/10.1038/s41590-019-0417-yFromNLM
Mora, J., Mertens, C., Meier, J. K., Fuhrmann, D. C., Brüne, B., & Jung, M. (2019). strategies to interfere with tumor metabolism through the interplay of innate and adaptive Immunity. Cells. https://doi.org/10.3390/cells8050445
Article PubMed PubMed Central Google Scholar
Murat, A., Migliavacca, E., Gorlia, T., Lambiv, W. L., Shay, T., Hamou, M. F., de Tribolet, N., Regli, L., Wick, W., Kouwenhoven, M. C., Hainfellner, J. A., Heppner, F. l., Dietrich, P-Y., Zimmer, Y., Cairncross, J. G., Janzer, R-C., Domany, E., Delorenzi, M., Stupp, R., and Hegi, M. E. (2008). Stem cell-related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. Journal of Clinical Oncology, 26(18), 3015–3024. https://doi.org/10.1200/jco.2007.15.7164FromNLM
Nakanishi, K. (2018). Unique action of interleukin-18 on T cells and other immune cells. Frontiers in Immunology, 9, 763. https://doi.org/10.3389/fimmu.2018.00763FromNLM
Article PubMed PubMed Central Google Scholar
Neftel, C., Laffy, J., Filbin, M. G., Hara, T., Shore, M. E., Rahme, G. J., Richman, A. R., Silverbush, D., Shaw, M. L., Hebert, C. M., Dewitt, J., Gritsch, S., Perez, E. M., Castro, L. N. G., Lan, X., Druck, N., Rodman, C., Dionne, D., Kaplan, A., Bertalan, M. S., Small, J., Pelton, K., Becker, S., Bonal, D., Nguyen, Q-D., Servis, R. L., Fung, J. M., Mylvaganam, R., Mayr, L., Gojo, J., Haberler, C., Geyeregger, R., Czech, T., Slavc, I., Nahed, B. V., Curry, W. T., Carter, B. S., Wakimoto, H., Brastianos, P. K., Batchelor, T. T., Stemmer-Rachamimov, A., Martinez-Lage, M., Frosch, M. P., Stamenkovic, I., Riggi, N., Rheinbay, E., Monje, M., Rozenblatt-Rosen, O., Cahill, D. P., Patel, A. P., Hunter, T., Verma, I. M., Ligon, K. L., Louis, D. N., Regev, A., Bernstein, B. E., Tirosh, I., and Suva, M. L. (2019). An integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell, 178(4), 835-849.e821. https://doi.org/10.1016/j.cell.2019.06.024FromNLM
Oh, S., Yeom, J., Cho, H. J., Kim, J. H., Yoon, S. J., Kim, H., Sa, J. K., Ju, S., Lee, H., Oh, M. J., Lee, W., Kwon, Y., Li, H., Choi, S., Han, J. H., Chang, J. H., Choi, E., Kim, J., Her, N-G., Kim, S. H., Kang, S-G., Paek, E., Nam, D-H., Lee, C., & Kim, H. S. (2020). Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities. Nature Communications, 11(1), 3288. https://doi.org/10.1038/s41467-020-17139-yFromNLM
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., Louis, D. N., Rozenblatt-Rosen, O., Suva, M. L., Regev, A., Bernstein, B. E. (2014). Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science, 344(6190), 1396–1401. https://doi.org/10.1126/science.1254257FromNLM
Perisé-Barrios, A. J., Gómez, R., Corbí, A. L., de la Mata, J., Domínguez-Soto, A., & Muñoz-Fernandez, M. A. (2015). Use of carbosilane dendrimer to switch macrophage polarization for the acquisition of antitumor functions. Nanoscale, 7(9), 3857–3866. https://doi.org/10.1039/c4nr04038dFromNLM
Poff, A., Koutnik, A. P., Egan, K. M., Sahebjam, S., D’Agostino, D., & Kumar, N. B. (2019). Targeting the Warburg effect for cancer treatment: Ketogenic diets for management of glioma. Seminars in Cancer Biology, 56, 135–148. https://doi.org/10.1016/j.semcancer.2017.12.011FromNLM
Article CAS PubMed Google Scholar
Pogribny, I. P. (2010). Ferroportin and hepcidin: A new hope in diagnosis, prognosis, and therapy for breast cancer. Breast Cancer Research, 12(5), 314. https://doi.org/10.1186/bcr2641FromNLM
Article PubMed PubMed Central Google Scholar
Radio, F. C., Majore, S., Aurizi, C., Sorge, F., Biolcati, G., Bernabini, S., Giotti, I., Torricelli, F., Giannarelli, D., De Bernardo, C., Grammatico, P. (2015). Hereditary hemochromatosis type 1 phenotype modifiers in Italian patients. The controversial role of variants in HAMP, BMP2, FTL and SLC40A1 genes. Blood Cells Molecules and Diseases. https://doi.org/10.1016/j.bcmd.2015.04.001FromNLM
Reardon, D. A., Wen, P. Y., Wucherpfennig, K. W., & Sampson, J. H. (2017). Immunomodulation for glioblastoma. Current Opinion in Neurology, 30(3), 361–369. https://doi.org/10.1097/wco.0000000000000451FromNLM
Article CAS PubMed Google Scholar
Sachamitr, P., Ho, J. C., Ciamponi, F. E., Ba-Alawi, W., Coutinho, F. J., Guilhamon, P., Kushida, M. M., Cavalli, F. M. G., Lee, L., Rastegar, N., Vu, V., Sánchez-Osuna, M., Coulombe-Huntington, J., Kanshin, E., Whetstone, H., Durand, M., Thibault, P., Hart, K., Mangos, M., Veyhl, J., Chen, W., Tran, N., Duong, B-C., Aman, A. M., Dirks, P. B. (2021). PRMT5 inhibition disrupts splicing and stemness in glioblastoma. Nature Communications, 12(1), 979. https://doi.org/10.1038/s41467-021-21204-5FromNLM
Sun, L., Hui, A. M., Su, Q., Vortmeyer, A., Kotliarov, Y., Pastorino, S., Passaniti, A., Menon, J., Walling, J., Bailey, R., Rosenblum, M., Mikkelsen, T., Fine, H. A. (2006). Neuronal and glioma-derived stem cell factor induces angiogenesis within the brai
留言 (0)